mobile btn
Friday, January 28th, 2022


AstraZeneca COVID-19 antibodies garner FDA approval

The U.S. Food and Drug Administration (FDA) approved this week an emergency use authorization (EUA) for AstraZeneca’s Evusheld, authorizing the use of monoclonal antibodies to reduce specific COVID-19 risk. Evusheld is tixagevimab co-packaged with cilgavimab and administered together to... Read More »

Congress eyes new international biothreat organization

Members of the U.S. House Foreign Affairs Committee expressed support for a proposed initiative that would create an international organization aimed at detecting and preventing new biological threats, either unintentionally developed or intentionally introduced by rogue actors, like terrorists or... Read More »

Silverlon receives FDA Breakthrough Device designation

Argentum Medical, a Geneva, Ill.-based medical device company, announced Tuesday that the U.S. Food and Drug Administration (FDA) had granted its Silverlon Wound Contact, Burn Contact Dressings a Breakthrough Device designation. The FDA’s Breakthrough Device Program creates a pathway for... Read More »

Oshkosh Defense secures Army JLTV contract

Oshkosh Corporation officials said a subsidiary of the company, Oshkosh Defense, has secured an Army contract totaling $591.6 million for 1,669 Joint Light Tactical Vehicles (JLTV). The contract, which was awarded via the Army Contracting Command – Detroit Arsenal (ACC-DTA), includes 868... Read More »

Huntington Ingalls Industries details Navy pact

Huntington Ingalls Industries announced that the company's Ingalls Shipbuilding division has received a $113.6 million Navy contract modification for the Amphibious Assault Ship LHA 9. The contract would enable long-lead-time material and advance procurement activities, bringing the total... Read More »